Chem p. 940 - 949 (2019)
Update date:2022-08-03
Topics:
Xiao, Haiwen
Liu, Zhonglin
Shen, Haigen
Zhang, Benxiang
Zhu, Lin
Li, Chaozhong
Direct trifluoromethylation of C(sp3)–H bonds, especially in late stages, remains a formidable challenge. Herein, we describe the copper-catalyzed benzylic C(sp3)–H trifluoromethylation. With Cu(I) or Cu(II) as the catalyst, (bpy)Zn(CF3)2 (bpy = 2,2′-bipyridine) as the CF3 source, and NFSI (or Selectfluor) as the oxidant, site-selective benzylic C(sp3)–H trifluoromethylation is successfully implemented in high efficiency under mild conditions. The protocol not only exhibits broad substrate scope and wide functional-group compatibility but also allows efficient late-stage C(sp3)–H trifluoromethylation of natural products or drug derivatives. The introduction of trifluoromethyl groups into organic molecules is of paramount importance in pharmaceuticals and agrochemicals because of their profound effect on properties such as lipophilicity, permeability, and metabolic stability. However, direct C(sp3)–H trifluoromethylation, which is most atom economical, remains a formidable challenge, and only a few examples with limited substrate scope and low to moderate efficiency have been reported to date. In this article, we introduce the copper-catalyzed benzylic C(sp3)–H trifluoromethylation with the easily available (bpy)Zn(CF3)2 complex as the CF3 source. This unprecedented protocol not only exhibits a high efficiency and broad substrate scope but also allows the late-stage trifluoromethylation of bioactive molecules or natural product derivatives. Because the procedure is operationally simple and the conditions are mild, the method should find immediate application in the synthesis of important trifluoromethylated molecules. Trifluoromethylated molecules are of paramount importance in pharmaceuticals and agrochemicals, but methods of making them by direct C(sp3)–H trifluoromethylation are extremely rare. In this issue of Chem, Li and coworkers describe a copper-catalyzed late-stage benzylic C–H trifluoromethylation with broad substrate scope and functional-group tolerance. The reaction may serve the late-stage modification of drug candidates.
View MoreContact:+86-15995924277
Address:WuZhongOu suzhou new south road 89
Contact:13813902930 025-52714267
Address:20 Fengji Road, Yuhua Economic Development Zone, Nanjing, Jiangsu, P. R. China
Shenzhen READLINE Technology Co., Ltd.
website:http://www.szreadline.com
Contact:+86-755-26659310
Address:A-3rd Floor, Wanhe Medical Park, No. 8, Gaoxin C.1st Ave, Nanshan District, Shenzhen, Guangdong, China.
Jinan Trio PharmaTech Co., Ltd
Contact:86-531-88811783;+(0)13153010282
Address:2766 Yingxiu Road, Jinan High-Tech Zone, China
Shanghai Normway Pharmachem Co.,Ltd.
Contact:86-21-50897098 13501889356
Address:2F No. 450 Husong Road Minhang District Shanghai China
Doi:10.1021/ja00410a036
(1981)Doi:10.1002/ardp.19773100904
(1977)Doi:10.1248/cpb.39.1193
(1991)Doi:10.1002/anie.202004747
(2020)Doi:10.1021/jo00161a024
(1983)Doi:10.1021/ol036133h
(2003)